Clinical Trials Directory

Trials / Conditions / Pachyonychia Congenita

Pachyonychia Congenita

12 registered clinical trials studyying Pachyonychia Congenita — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEpidermal Growth Factor Receptor Inhibition for Keratinopathies
NCT06545695
Northwestern UniversityPhase 1 / Phase 2
CompletedAssessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
NCT05956314
Kamari Pharma LtdPhase 1
RecruitingA Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of
NCT05643872
Palvella Therapeutics, Inc.Phase 3
CompletedStudy Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmopla
NCT05435638
Kamari Pharma LtdPhase 1
CompletedA Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy o
NCT05180708
Palvella Therapeutics, Inc.Phase 3
CompletedVALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congen
NCT04520750
Palvella Therapeutics, Inc.Phase 3
CompletedPhase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congeni
NCT03920228
Palvella Therapeutics, Inc.Phase 2 / Phase 3
CompletedEffect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
NCT02592954
Johns Hopkins UniversityPhase 1
CompletedTopical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
NCT02152007
TransDerm, Inc.Phase 1
UnknownSimvastatin Treatment of Pachyonychia Congenita
NCT01382511
Tel-Aviv Sourasky Medical CenterN/A
CompletedStudy of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
NCT00716014
Pachyonychia Congenita ProjectPhase 1
RecruitingInternational Pachyonychia Congenita Research Registry
NCT02321423
Pachyonychia Congenita Project—